SAN DIEGO--(BUSINESS WIRE)--Aug 30, 2018--Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invited investors to participate via webcast.

Morgan Stanley Annual Global Healthcare Conference in New York, NY Thursday, September 13, 2018 at 1:30pm Eastern Time

The live webcast can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com. A replay of the presentation will be posted on Illumina’s web site after the event and will be available for at least 30 days following.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit  www.illumina.com  and follow @illumina.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180830005743/en/

CONTACT: Illumina, Inc.

Investors:

Jacquie Ross, CFA

858-882-2172

ir@illumina.com

or

Media:

Eric Endicott

858-882-6822

pr@illumina.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS RESEARCH SCIENCE

SOURCE: Illumina, Inc.

Copyright Business Wire 2018.

PUB: 08/30/2018 04:05 PM/DISC: 08/30/2018 04:05 PM

http://www.businesswire.com/news/home/20180830005743/en